Active surveillance for prostate cancer: A systematic review of contemporary worldwide practices
Translational Andrology and Urology , Volume 7 - Issue 1 p. 83- 97
In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-risk prostate cancer (PC), however there is discordance amongst large AS cohort studies with respect to entry and monitoring protocols. We systematically reviewed worldwide AS practices in studies reporting =5 years follow-up. We searched PubMed and Medline 2000-now and identified 13 AS cohorts. Three key areas were identified: (I) patient selection; (II) monitoring protocols; (III) triggers for intervention-(I) all studies defined clinically localised PC diagnosis as T2b disease or less and most agreed on prostate-specific antigen (PSA) threshold ( < 10 μg/L) and Gleason score threshold (3+3). Inconsistency was most notable regarding pathologic factors (e.g., number of positive cores); (II) all agreed on PSA surveillance as crucial for monitoring, and most agreed that confirmatory biopsy was required within 12 months of initiation. No consensus was reached on optimal timing of digital rectal examination (DRE), general health assessment or re-biopsy strategies thereafter; (III) there was no universal agreement for intervention triggers, although Gleason score, number or percentage of positive cancer cores, maximum cancer length (MCL) and PSA doubling time were used by several studies. Some also used imaging or re-biopsy. Despite consistent high progression-free/cancer-free survival and conversion-to-treatment rates, heterogeneity exists amongst these large AS cohorts. Combining existing evidence and gathering more long-term evidence [e.g., the Movember's Global AS database or additional information on use of magnetic resonance imaging (MRI)] is needed to derive a broadly supported guideline to reduce variation in clinical practice.
|Active surveillance (AS), Cohort study, Prostate cancer (PC)|
|Translational Andrology and Urology|
|Organisation||Department of Urology|
Kinsella, N. (Netty), Helleman, J, Bruinsma, S.M, Carlsson, S, Cahill, D. (Declan), Brown, C. (Christian), & Van Hemelrijck, M. (Mieke). (2018). Active surveillance for prostate cancer: A systematic review of contemporary worldwide practices. Translational Andrology and Urology, 7(1), 83–97. doi:10.21037/tau.2017.12.24